Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
YESCARTA (Kite/Gilead)
(https://yescarta.com) 📸 Data Snapshot: June 20, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE YESCARTA® (axicabtagene ciloleucel) Patient & Caregiver Site | CAR T-Cell Therapy for Certain Types of Non-Hodgkin Lymphoma in Adults (https://yescarta.com)
YESCARTA® (axicabtagene ciloleucel) Patient & Caregiver Site | CAR T-Cell Therapy for Certain Types of Non-Hodgkin Lymphoma in Adults
Learn about YESCARTA® (axicabtagene ciloleucel) a CAR T-cell therapy for certain types of non-Hodgkin lymphoma in adults. See Important Safety Information & Warnings.
NAV_HEADER_REPEATED_BODY Managing YESCARTA® (axicabtagene ciloleucel) Side Effects | Patient & Caregiver Site (https://yescarta.com/managing-side-effects/)
Managing YESCARTA® (axicabtagene ciloleucel) Side Effects | Patient & Caregiver Site
Learn about the possible side effects of YESCARTA® (axicabtagene ciloleucel) and how treatment teams, caregivers, and patients manage these side effects. See Important Safety Information & Warnings.
NAV_HEADER_REPEATED_BODY Support and Resources | YESCARTA® (axicabtagene ciloleucel) | Patient & Caregiver Site (https://yescarta.com/support-and-resources/)
Support and Resources | YESCARTA® (axicabtagene ciloleucel) | Patient & Caregiver Site
Learn about the types of support and resources that may be helpful throughout treatment and who to ask for help. See Important Safety information & Warnings.
NAV_HEADER_REPEATED_BODY_FOOTER YESCARTA® (axicabtagene ciloleucel) Clinical Trial Results | Patient & Caregiver Site (https://yescarta.com/clinical-trial-results/)
YESCARTA® (axicabtagene ciloleucel) Clinical Trial Results | Patient & Caregiver Site
Learn about how patients responded to YESCARTA® (axicabtagene ciloleucel) in clinical trials. See Important Safety Information & Warnings.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://yescarta.com) YESCARTA® (axicabtagene ciloleucel) Patient & Caregiver Site | CAR T-Cell Therapy for Certain Types of Non-Hodgkin Lymphoma in Adults
[H1] YESCARTA® is a CAR T-cell therapy made from your own immune system. [H3] It has helped many patients reach a complete and lasting remission.* *Complete remission (also known as complete response) is the disappearance of all signs of cancer. It does not always mean that the cancer has been cured. [IMG: What to know about CAR T patient video thumbnail.] Video: What to know about CAR T This testimonial is representative of patients' and caregivers' own experiences. Individual treatment results and experience may vary. YESCARTA may be an option for some patients with Large B-Cell Lymphoma (LBCL) or Follicular Lymphoma (FL). [H2] Why YESCARTA? Over 25,000 patients have been treated with YESCARTA since it was approved in 2017.1 While there are multiple steps in the treatment process, YESCARTA is a one-time infusion.2 1As of July 2025, this number includes global internal Kite commercial and clinical trial data. 2Not including pre-treatment or low-dose chemotherapy. [IMG: Purple circle icon with 2x text.] 2nd line LBCL Two years after treatment, patients who received YESCARTA were more than twice as likely to stay event free compared to patients who received standard therapy. Event-free survival is the length of time after treatment that patients go without having their cancer come back, get worse, or experience any other complications or worsening of symptoms. Learn more [IMG: First and only approved CAR T treatment in adult 2L LBCL] [IMG: 7 in 10 patients circles icon.] Ask your doctor if YESCARTA is an option for you. [H2] Starting Points Explore information that may be helpful to you at different stages of treatment: Who YESCARTA is for and how it works chevron_right Important considerations for YESCARTA chevron_right How YESCARTA worked for other patients chevron_right Side effects and how they are managed chevron_right Information about insurance coverage chevron_right Treatment steps and preparation guide chevron_right YESCARTA infusion and close daily monitoring chevron_right Continued monitoring for side effects chevron_right Get help finding information on YESCARTA, resources, and support chevron_right Caregiver role and support chevron_right Managing side effects at home chevron_right Support and resources along the way chevron_right Caregiver role and support chevron_right Have questions? Call us Your treatment team is the best resource for support throughout treatment. If you have questions at any step of the CAR T process, our dedicated team at Kite can also help. You can call them at: 1-844-454-KITE [5483]5483 Monday–Friday 8 am–9 pm ET 5 am–6 pm PT [H4] You are now leaving YESCARTA.com The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website. [H4] You are now leaving YESCARTA.com You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to remain on the patient site, please select cancel. [H3] Treatment center locator tool There are over 160 cancer centers that provide YESCARTA throughout the US. When choosing a location, consider that you will need to stay close to a healthcare facility for at least 2 weeks after receiving YESCARTA. You can use the locator tool to find and learn about nearby treatment centers and their teams. Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more. Traveling From Typical driving times around your location 1 hour 2 hours Copy link Print information Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options. Find a treatment center near you that offers YESCARTA: Find a treatment center near you that offers YESCARTA: Find a treatment center Approved Uses YESCARTA is a prescription medicine used to treat two types of non-Hodgkin lymphoma ... Important Safety Information What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that are life-threatening and can lead to death ... Approved Uses and Important Safety Information Read Approved Uses YESCARTA® is a prescription medicine used to treat two types of non-Hodgkin lymphoma: large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer. follicular lymphoma when at least two kinds of treatment have failed to control your cancer. YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells. Important Safety Information What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following: Fever (100.4°F/38°C or higher) Difficulty breathing Chills or shaking chills Confusion Dizziness or lightheadedness Severe nausea, vomiting, or diarrhea Fast or irregular heartbeat Severe fatigue or weakness It is important to tell your healthcare provider that you received YESCARTA. Your healthcare provider may give you other medicines to treat your side effects. Before getting YESCARTA, tell your healthcare provider about all your medical problems, including if you have or have had: Neurologic problems (such as seizures, stroke, or memory loss) Lung or breathing problems Heart problems Liver problems Kidney problems A recent or active infection Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. How will I receive YESCARTA? Since YESCARTA is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells. Your blood cells will be sent to a manufacturing center to make your YESCARTA. Before you get YESCARTA, you will get 3 days of chemotherapy to prepare your body. When your YESCARTA is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes. You will be monitored daily for at least 7 days after the infusion. You should plan to stay close to a healthcare facility for at least 2 weeks after getting YESCARTA. Your healthcare provider will help you with any side effects that may occur. You may be hospitalized for side effects and your healthcare provider will discharge you if your side effects are under control, and it is safe for you to leave the hospital. Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule. What should I avoid after receiving YESCARTA? Avoid driving for at least 2 weeks after you get YESCARTA. Do not donate blood, organs, tissues, or cells for transplantation. What are the possible or reasonably likely side effects of YESCARTA? The most common side effects of YESCARTA include: Fever (100.4°F/38°C or higher) Low white blood cells (can occur with a fever) Low red blood cells Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath) Fast heartbeat Confusion Difficulty speaking or slurred speech Nausea Diarrhea YESCARTA may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this. These are not all the possible side effects of YESCARTA. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts, including IMPORTANT WARNINGS before you receive YESCARTA. You’ve reached the end of the Approved Uses and Important Safety Information. Click “Okay” to minimize the tray. You can reopen the full information at any time by clicking the “Read” button at the bottom of the screen.
SUB-PAGE (https://yescarta.com/managing-side-effects/) Managing YESCARTA® (axicabtagene ciloleucel) Side Effects | Patient & Caregiver Site
[H1] Managing side effects [IMG: medical-professional-helping-patient-manage-side-effects] On this page What are the possible side effects of YESCARTA? How will the treatment team manage side effects and keep me safe? What is my role in managing side effects? During YESCARTA infusion and close monitoring During continued monitoring During recovery at home Patient and caregiver perspectives [H2] What are the possible side effects of YESCARTA? Because YESCARTA is a treatment that works on your immune system, there is a risk that your immune system may become overactive and affect the rest of your body in unwanted ways. You can learn about the possible side effects of YESCARTA by reading the Important Safety Information. Two side effects that many patients have experienced are Cytokine Release Syndrome (CRS)? and Neurotoxicity?: CRS and Neurotoxicity can become life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following: Fever (100.4°F/38°C or higher) Difficulty breathing Chills or shaking chills Confusion Dizziness or lightheadedness Severe nausea, vomiting, or diarrhea Fast or irregular heartbeat Severe fatigue or weakness It is important to tell your healthcare provider that you received YESCARTA. Your healthcare provider may give you other medicines to treat your side effects. The most common side effects of YESCARTA include: Fever (100.4°F/38°C or higher) Low white blood cells (can occur with a fever) Low red blood cells Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath) Fast heartbeat Confusion Difficulty speaking or slurred speech Nausea Diarrhea YESCARTA may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this. These are not all the possible side effects of YESCARTA. It’s important to talk to your treatment team about how you are feeling, and let them know if you notice any symptoms. Each person's experience and potential side effects will be different. [H2] How will the treatment team manage side effects and keep me safe? Your safety and care are top priority. There will be multiple safety measures in place throughout your YESCARTA treatment experience: [H2] What is my role in managing side effects? Both patients and caregivers play an important role during CAR T treatment. See below for what you can do and how your responsibilities may shift throughout treatment. Remember that you can always ask your treatment team if you have questions about side effects and how to look for them. [H2] During YESCARTA infusion and close daily monitoring To help prepare for your CAR T-cell infusion, your treatment team may give you premedications. You will be monitored daily for at least 1 week after infusion in case serious side effects happen. During this time, you will be under the care of your treatment team. Serious side effects are most likely in the first few weeks after infusion. Your treatment team is well equipped to manage and treat side effects. They will regularly complete health checks? and ask you to do some simple tasks? to identify and track any symptoms. If needed, they may treat CRS or neurotoxicity with corticosteroids or other medications. [IMG: A patient with the oncologist and caregiver during YESCARTA® (axicabtagene ciloleucel) infusion at the certified treatment center] Your treatment team is well equipped to manage and treat side effects. They will regularly complete health checks? and ask you to do some simple tasks? to identify and track any symptoms. If needed, they may treat CRS or neurotoxicity with corticosteroids or other medications. [H4] What you can do Proactively tell the treatment team if you notice any changes in how you're feeling. Caregivers may be the first to notice side effects, as some symptoms can be difficult for patients to recognize by themselves. The treatment team can also answer any questions you may have about side effects and how to look for them. Learn more about what to expect and how to prepare for this step on the Receiving YESCARTA page. “Every day while I was in the hospital, each shift of nurses would have me write my name on a piece of paper, ask me what day it was, and ask me to identify five different objects in my room.” MargaretYESCARTA Patient This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary. [IMG: Margaret YESCARTA® (axicabtagene ciloleucel) patient ambassador looking out the window.] This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary. [H2] During continued monitoring You should plan to stay close to a healthcare facility for at least 2 weeks after infusion, so you can get help quickly if any side effects occur. Your treatment team will let you know where this continued monitoring will take place. Avoid driving for at least 2 weeks after infusion. [IMG: A caregiver taking a patient] [H4] What you can do Follow your treatment team’s instructions for monitoring for signs and symptoms of side effects. You will be responsible for monitoring side effects once you’ve left the center. Notify your treatment team immediately if you notice any changes. Receiving medical attention right away may keep side effects from becoming more serious. It is important to tell any healthcare providers you visit that you received YESCARTA, and have your treatment team’s contact information on hand. Learn more about what to expect and how to prepare for this step on the Receiving YESCARTA page. “I was hyper-aware of every little change my body was going through, and it was a little overwhelming! My mom and I had a detailed schedule for when to take meds, blood pressure, and temperature. We had alarms on our phones and a checklist to make sure we didn't miss anything.” LayraYESCARTA Patient This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary. [IMG: Laura comforting Layra, a YESCARTA® (axicabtagene ciloleucel) patient ambassador.] This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary. [H2] During recovery at home When the treatment team thinks you are ready—at least 2 weeks after infusion—you'll no longer be required to stay near a healthcare facility. If you had to travel for treatment, this means you can now return home. You may also start returning to your local oncologist for follow-up appointments. [IMG: A caregiver continuing to take care of a recovering patient at home.] [H4] What you can do Continue to look out for side effects and talk to your healthcare teams about how you are feeling. Make sure to attend follow-up appointments. If you miss an appointment, it’s important to reschedule as soon as possible. You should continue to tell any healthcare providers you visit that you received YESCARTA. Learn more about what to expect and how to prepare for this step on the Receiving YESCARTA page. “When we were in the hospital, if something went wrong, I could just stick my head out the door and a whole medical team would be there. At home, we don’t have that. But I had the numbers for emergency help and knowing that was available to me made me feel better.” SkipYESCARTA Caregiver This testimonial is representative of the caregiver’s own experience. Individual treatment results and experience may vary. [IMG: Caregiver ambassador Skip shows Margaret, a YESCARTA® (axicabtagene ciloleucel) patient ambassador, information on the computer.] This testimonial is representative of the caregiver’s own experience. Individual treatment results and experience may vary. [H2] Patient and caregiver perspectives This testimonial is representative of patients’ and caregivers’ own experiences. Individual treatment results and experience may vary. [IMG: Patient and caregiver monitoring side effects video thumbnail.] Monitoring side effects Learn more about what side effect monitoring was like for YESCARTA patients and caregivers Play Video play_arrow Have questions? Call us Your treatment team is the best resource for support throughout treatment. If you have questions at any step of the CAR T process, our dedicated team at Kite can also help. You can call them at: 1-844-454-KITE [5483]5483 Monday–Friday 8 am–9 pm ET 5 am–6 pm PT [H3] Certified treatment centers In order to provide YESCARTA, cancer treatment centers must first be certified. Certified treatment centers have specifically-trained medical staff, strict treatment protocols, and safety measures in place for CAR T-cell therapy. These centers are often first to use best care practices learned through research. Certified treatment centers are sometimes known as authorized treatment centers, or certified healthcare facilities. Back to Top expand_less [H4] You are now leaving YESCARTA.com The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website. [H4] You are now leaving YESCARTA.com You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to remain on the patient site, please select cancel. [H3] Treatment center locator tool There are over 160 cancer centers that provide YESCARTA throughout the US. When choosing a location, consider that you will need to stay close to a healthcare facility for at least 2 weeks after receiving YESCARTA. You can use the locator tool to find and learn about nearby treatment centers and their teams. Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more. Traveling From Typical driving times around your location 1 hour 2 hours Copy link Print information Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options. [H3] Cytokine Release Syndrome (CRS) SY-toh-kine reh-LEES SIN-drome CRS happens when your immune system becomes overactive. After infusion, when the modified T cells recognize and kill cancer cells, they may release proteins called cytokines. A buildup of cytokines can lead to symptoms including: fever chills rapid heart rate low blood pressure low blood oxygen level CRS can last for about a week and typically occurs in the first few days after infusion, when you are staying at the treatment center under the care of the treatment team. [H3] Neurotoxicity NOOR-oh-tok-SIH-sih-tee Neurotoxicity is a side effect that happens when there is damage to the brain and spinal cord. Neurotoxicity can cause symptoms like: changes in the way the brain functions seizures changes in level of consciousness difficulty with speech tremors confusion Symptoms of neurotoxicity can last for 2–3 weeks and typically begin 4–5 days after YESCARTA infusion. Approved Uses YESCARTA is a prescription medicine used to treat two types of non-Hodgkin lymphoma ... Important Safety Information What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that are life-threatening and can lead to death ... Approved Uses and Important Safety Information Read Approved Uses YESCARTA® is a prescription medicine used to treat two types of non-Hodgkin lymphoma: large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer. follicular lymphoma when at least two kinds of treatment have failed to control your cancer. YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells. Important Safety Information What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following: Fever (100.4°F/38°C or higher) Difficulty breathing Chills or shaking chills Confusion Dizziness or lightheadedness Severe nausea, vomiting, or diarrhea Fast or irregular heartbeat Severe fatigue or weakness It is important to tell your healthcare provider that you received YESCARTA. Your health
SUB-PAGE (https://yescarta.com/support-and-resources/) Support and Resources | YESCARTA® (axicabtagene ciloleucel) | Patient & Caregiver Site
[H1] Support and resources [IMG: Patient support treatment team.] On this page Is YESCARTA covered by insurance? Who can help me find information on resources and support? Where else can I find support? YESCARTA video library Downloadable resources [H2] Is YESCARTA covered by insurance? Many insurance plans provide coverage for treatment. You can talk to your healthcare team to discuss all the costs associated with YESCARTA, including out-of-pocket costs?. How do I find out if my insurance covers YESCARTA? chevron_right If you don't have insurance, talk to your healthcare team about options available to you. There are other organizations that may be able to provide support if you are prescribed YESCARTA. [H2] Who can help me find information on resources and support? You don't have to figure everything out by yourself. Your treatment team is the best resource for support throughout treatment. Our knowledgeable team at Kite is also dedicated to helping answer your questions about the treatment process. You can call them at: 1-844-454-KITE [5483] Monday–Friday 8 am–9 pm ET or 5 am–6 pm PT [IMG: Individual talking to Kite Team on the phone.] [H2] Where else can I find support? Many organizations offer help throughout the process. The lists below are a starting point for finding organizations that may offer assistance programs. This is not an exhaustive list of support programs. You can ask your treatment team about other support that might be available. Resources may include referrals to independent third-party nonprofit patient assistance programs. These programs are not operated or controlled by Kite, and Kite does not endorse any program or third-party organization. Nonprofit patient assistance program eligibility requirements may vary and are established solely by each independent organization. Kite makes no guarantee with respect to reimbursement or copay assistance for any item or service. Financial support chevron_right Travel and lodging support chevron_right Day-to-day support chevron_right Mental health, emotional support, and peer groups chevron_right Physical wellness support chevron_right Educational support chevron_right “There are things that you absolutely won't be able to do for yourself. When I needed something, I asked my caregiver, treatment team, friends, and neighbors. Don't be afraid—you'll be surprised how many people want to help.” MargaretYESCARTA Patient This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary. [IMG: Margaret YESCARTA® (axicabtagene ciloleucel) patient ambassador baking with caregiver Skip.] This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary. There are also additional resources available just for caregivers. You can find links on the Caregiver support page. [H2] YESCARTA video library Patient and caregiver perspectives: These testimonials are representative of patients’ and caregivers' own experiences. Individual treatment results and experience may vary. [IMG: Patient CAR T infusion video thumbnail.] What to know about CAR T Learn about what was important to other patients and caregivers Play Video play_arrow [IMG: Patient and caregiver treatment experience video thumbnail.] The treatment process Listen to patients and caregivers talk about their experience with YESCARTA treatment Play Video play_arrow [IMG: A patient after YESCARTA® (axicabtagene ciloleucel) treatment video thumbnail.] After treatment Listen to patients and caregivers talk about recovery and life after YESCARTA treatment Play Video play_arrow [IMG: Patient and caregiver monitoring side effects video thumbnail.] Monitoring side effects Learn more about what side effect monitoring was like for YESCARTA patients and caregivers Play Video play_arrow [IMG: Caregiver care video thumbnail.] Caregiver well-being Caregivers talk about the importance of caring for themselves during YESCARTA treatment Play Video play_arrow Learn about YESCARTA and the YESCARTA treatment process. These animations may help you explain YESCARTA and the YESCARTA treatment process to family and friends. [IMG: Video thumbnail showing T cells and how CAR T works.] What is CAR T-cell therapy? Play Video play_arrow [IMG: YESCARTA® (axicabtagene ciloleucel) treatment process video thumbnail.] What is the treatment process? Play Video play_arrow [H2] Downloadable resources YESCARTA Patient Wallet Card chevron_right YESCARTA Treatment Overview Book: English chevron_right YESCARTA Treatment Overview Book: Español chevron_right Have questions? Call us Your treatment team is the best resource for support throughout treatment. If you have questions at any step of the CAR T process, our dedicated team at Kite can also help. You can call them at: 1-844-454-KITE [5483]5483 Monday–Friday 8 am–9 pm ET 5 am–6 pm PT Back to Top expand_less [H4] You are now leaving YESCARTA.com The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website. [H4] You are now leaving YESCARTA.com You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to remain on the patient site, please select cancel. [H3] Treatment center locator tool There are over 160 cancer centers that provide YESCARTA throughout the US. When choosing a location, consider that you will need to stay close to a healthcare facility for at least 2 weeks after receiving YESCARTA. You can use the locator tool to find and learn about nearby treatment centers and their teams. Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more. Traveling From Typical driving times around your location 1 hour 2 hours Copy link Print information Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options. [H3] Out-of-pocket costs There are out-of-pocket costs involved in the CAR T treatment process. ‘Out-of-pocket’ is any cost a patient has that is not covered by a health insurance plan. Examples include deductibles, co-payments for covered services, and costs for services that are not covered. [H3] How do I find out if my insurance covers YESCARTA? [IMG: Individual calling insurance provider for coverage information.] If you're considering YESCARTA, your treatment team will look into your insurance coverage as part of the CAR T consultation process. They will work with your insurance provider to determine what your coverage will be. They can also answer any questions you may have. You may need to provide the following information in order to review your insurance coverage: Your oncologist's name and phone number The name of your treatment center and location Your insurance member ID # Other information about your plan, which can be found on your insurance card [H3] Financial support [H4] American Cancer Society Patient Programs and Services for help during and after cancer treatment [H4] Bone Marrow & Cancer Foundation Financial Assistance Programs financial assistance for patients and their families [H4] BMT InfoNet Patient Assistance Fund helps with living expenses during treatment [H4] CancerCare Financial & Co-Payment Assistance helps with treatment-related costs and finding additional resources [H4] Cancer Support Community Helpline financial navigation, and treatment lodging and transportation resources, and other services [H4] Family Reach Foundation Get Help financial assistance, tips, and resource navigation [H4] Leukemia & Lymphoma Society Financial Support a list of financial assistance programs [H4] Lymphoma Research Foundation Helpline phone or email service for financial assistance resources and other information Patient Aid Grant limited financial assistance to patients who are underinsured or struggle to pay for medical expenses [H4] National Cancer Institute Managing Costs and Medical Information [H4] Patient Advocate Foundation Patient Advocate Foundation a selection of services that address financial and other obstacles to accessing healthcare The organizations listed above are independent from Kite and Gilead, and this list is subject to change. This information is provided as a resource for patients and is not an endorsement or guarantee of assistance. [H3] Travel and lodging support [H4] Air Care Alliance Patient and Medical Transport organizes flights to help patients access distant medical care [H4] American Cancer Society Hope Lodge home-like lodging environments for patients undergoing treatment Patient Programs and Services programs providing financial assistance, travel, lodging support, and more Road to Recovery transportation to and from treatment [H4] BMT InfoNet Patient Assistance Fund helps with living expenses during treatment [H4] Cancer Support Community Helpline treatment lodging and transportation resources, financial navigation, and other services [H4] Corporate Angel Network Corporate Angel Network arranges free air travel for cancer patients on corporate planes [H4] Footprints in the Sky Footprints in the Sky arranges free air travel for patients on charter and corporate planes [H4] Grace On Wings Grace On Wings provides charity air ambulance services [H4] Healthcare Hospitality Network Need medical lodging? a tool to search for a place to stay near your treatment center [H4] Joe’s House Joe’s House helps patients find affordable places to stay when traveling for medical treatment [H4] Leukemia & Lymphoma Society Financial Support a list of financial assistance programs, including lodging, transportation, and other non-medical expenses [H4] Mercy Medical Angels Mercy Medical Angels assists with the cost of ground and air travel for patients needing to access medical care [H3] Day-to-day support [H4] American Cancer Society Patient Programs and Services Road to Recovery program provides rides to patients to get to their cancer treatment [H4] CancerCare Resource Navigation navigators and oncology social workers help connect patients and caregivers to resources Pet Assistance and Wellness Program assists with keeping a cat or dog at home while going through cancer treatment [H4] Cancer Support Community Helpline treatment lodging and transportation resources, financial navigation, and other services [H4] Leukemia & Lymphoma Society Meals at Your Door meal delivery service One-On-One Nutrition Consultations with registered dieticians [H3] Mental health, emotional support, and peer groups [H4] BMT InfoNet Coping with Stress During CAR T-cell Therapy Caring Connections Program talk to a patient or caregiver who has been through CAR T treatment [H4] Cancer.net Counseling information about counseling and finding a counselor Resources for LGBTQ+ People Support Groups information about support groups and how to find one [H4] CancerCare Support Groups led by professional oncology social workers Counseling Young Adults information, resources, and support for young adults affected by cancer Older Adults information, resources, and support to help older people cope with cancer [H4] Cancer Support Community MyLifeLine online community of patients, survivors, and caregivers [H4] Leukemia & Lymphoma Society Support Groups search for support groups for anyone affected by blood cancer Patti Robinson Kaufmann First Connection® Program peer-to-peer support [H4] Lymphoma Research Foundation Lymphoma Support Network a one-to-one peer support program [H4] Patient Empowerment Network Non-Hodgkin’s Lymphoma Friends a peer support community for patients living with Non-Hodgkin’s Lymphoma, and their caregivers [H3] Physical wellness support [H4] American Cancer Society Coping and Living Well During Cancer Treatment [H4] American Institute for Cancer Research Tips throughout treatment [H4] CancerCare Information about nutrition Information about sleep [H4] Cancer Support Community Exercise for wellness gui
SUB-PAGE (https://yescarta.com/clinical-trial-results/) YESCARTA® (axicabtagene ciloleucel) Clinical Trial Results | Patient & Caregiver Site
[H1] YESCARTA results [IMG: Medical professionals studying results.] On this page How has YESCARTA been studied? For LBCL patients whose cancer returned after their first treatment What are the results from the other YESCARTA clinical trials? Where can I learn more about the possible side effects of YESCARTA? [H2] How has YESCARTA been studied? YESCARTA has been studied across multiple clinical trials to look at how well it works, how safe it is, and who it might help. The FDA has approved YESCARTA for multiple uses based on the outcomes of these trials. [H2] For LBCL patients whose cancer returned after their first treatment: YESCARTA showed improved results compared to standard therapy. Trial in LBCL (2nd line) A clinical trial looked at adult patients with Large B-Cell Lymphoma who have tried one previous treatment that didn’t work or the cancer came back within 12 months (also called 2nd line). The goal of this trial was to see if YESCARTA improved the clinical outcome for patients when compared to standard therapy?. Standard therapy in this trial included chemoimmunotherapy, high-dose therapy, and autologous stem cell transplant, depending on how the cancer responded to treatment. Trial design Results and highlights [IMG: Purple circle icon with 2x text] [IMG: First and only approved CAR T treatment in adult 2L LBCL] [H2] What are the results from the other YESCARTA clinical trials? Other key clinical trials looked at how YESCARTA works for adult patients with different types of relapsed/refractory (R/R) cancer and treatment histories. Click below to see the clinical trial results for the cancer type you want to learn more about: Talk to your healthcare team if you want to learn more about the clinical trial results for your type of blood cancer. There are ongoing clinical trials to see if YESCARTA can be used safely and effectively in other situations. “My post-CAR T scan showed I was officially in remission! It was a day I had hoped for but feared wouldn’t come. A couple of weeks after that I felt the weight lift from my shoulders.” LayraYESCARTA Patient This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary. [IMG: Layra YESCARTA® (axicabtagene ciloleucel) patient ambassador looking in mirror.] This testimonial is representative of the patient’s own experience. Individual treatment results and experience may vary. [H2] Where can I learn more about the possible side effects of YESCARTA? Patients in YESCARTA clinical trials also experienced side effects. You can learn more about these side effects by: reading the Important Safety Information. visiting the Managing side effects page to learn more about how to look out for side effects. talking to your treatment team. Have questions? Call us Your treatment team is the best resource for support throughout treatment. If you have questions at any step of the CAR T process, our dedicated team at Kite can also help. You can call them at: 1-844-454-KITE [5483]5483 Monday–Friday 8 am–9 pm ET 5 am–6 pm PT Back to Top expand_less [H4] You are now leaving YESCARTA.com The website you are navigating to is not operated or controlled by Kite. Kite is not responsible for the information contained in the linked website. [H4] You are now leaving YESCARTA.com You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to remain on the patient site, please select cancel. [H3] Treatment center locator tool There are over 160 cancer centers that provide YESCARTA throughout the US. When choosing a location, consider that you will need to stay close to a healthcare facility for at least 2 weeks after receiving YESCARTA. You can use the locator tool to find and learn about nearby treatment centers and their teams. Information on new centers (where available) will be added on an ongoing basis. You can also contact your treatment team to learn more. Traveling From Typical driving times around your location 1 hour 2 hours Copy link Print information Treatment centers are independent facilities that dispense Kite CAR T therapies. Choice of a treatment center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites. Insurance coverage should be considered when reviewing treatment center options. [H3] Standard therapy A standard therapy is a treatment that is accepted by doctors as a suitable and widely used treatment for a certain type of disease. Also called “standard of care.” [H3] Overall survival Overall survival (OS) is the length of time that patients remain alive after starting a treatment. Researchers and doctors use overall survival data to help determine how well a treatment works. [H3] Event-free survival In clinical trials, an event is when a patient’s cancer comes back, gets worse, or experiences any other complications or worsening of symptoms. Event free means a patient has not experienced an event. Event-Free Survival (EFS) measures the length of time after treatment that patients go without having an event. Researchers and doctors use event-free survival data to help determine how well a treatment works. Approved Uses YESCARTA is a prescription medicine used to treat two types of non-Hodgkin lymphoma ... Important Safety Information What is the most important information I should know about YESCARTA? YESCARTA may cause side effects that are life-threatening and can lead to death ... Approved Uses and Important Safety Information Read
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /managing-side-effects/ | 8 | 0 |
| /support-and-resources/ | 5 | 0 |
| /clinical-trial-results/ | 3 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: YESCARTA (Kite/Gilead) (yescarta.com)
A model of low-BS pharmaceutical communication that prioritizes regulatory compliance and clinical specificity over marketing hyperbole. The site delivers a high volume of ‘inconvenient’ safety data alongside its efficacy claims, which serves as a significant bullshit-reducing signal. Only the lack of technical schema and direct journal citations prevent a perfect score.
Implement MedicalTherapy and Organization schema to provide machine-readable authority signals and link to Kite/Gilead sameAs profiles. Add a ‘References’ section on the Clinical Results page with direct outbound links to the published ZUMA trial results in peer-reviewed journals. Reduce repetition of the ‘one-time infusion’ value prop across the ‘Support’ page to focus more on logistical evidence. Explicitly link to the FDA approval letter to move from ‘Trust Theatre’ to ‘Verified Proof.’
The site is perfectly aligned with the Pharma and Biotech industry, specifically the CAR T-cell therapy sector. The presence of mandatory Important Safety Information (ISI) and specific medical indications for LBCL and FL confirms high industry relevance.
“The score is primarily driven by technical authority gaps (missing schema) and the inherent template-like nature of pharma websites. The Information Density and Semantic Coherence pillars scored nearly perfectly due to the high volume of specific, qualified medical data. Total BS Score: 18.”
This training module utilizes a snapshot of public data from YESCARTA (Kite/Gilead), captured on June 20, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to YESCARTA (Kite/Gilead): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://yescarta.com to view the most current version of its content and learn from the source what this company is about and what it offers.